 Short-term changes renal function blood pressure electrolyte levels patients cyclosporine dermatologic disorders changes renal function blood pressure BP concentrations serum potassium magnesium urate uric acid groups patients transplants Group psoriatic patients mg/kg day oral cyclosporine weeks prospective placebo-controlled study group patients diverse cutaneous diseases mg/kg day oral cyclosporine months prospective open-labeled study Renal function serum urea nitrogen SUN creatinine levels urinalysis BP serum electrolyte levels potassium magnesium urate level first weeks groups months therapy group first weeks group patients significant increases values SUN creatinine BP potassium urate significant decrease serum magnesium value data groups changes pretherapy values measures systolic BP first weeks cyclosporine trough levels group changes first weeks SUN value SUN/creatinine ratio BP subsequent weeks treatment combined group first weeks therapy duration therapy independent cyclosporine trough levels changes SUN creatinine urate levels changes potassium magnesium level BP cyclosporine blood level discriminant cyclosporine dosage analysis renal dysfunction hypertension patients